Brief: Morphosys And Novartis Sign Delisting Agreement

Morphosys AG

20/06/2024 07:30

June 20 (Reuters) - MORPHOSYS AG  MORG.DE :
    * MORPHOSYS AND NOVARTIS SIGN DELISTING AGREEMENT AND INTEND
TO
IMPLEMENT A MERGER SQUEEZE-OUT OF MORPHOSYS’ MINORITY
SHAREHOLDERS
    * MORPHOSYS AG - ACCEPTANCE PERIOD OF TAKEOVER OFFER AND
STATUTORY
TWO-WEEK ADDITIONAL ACCEPTANCE PERIOD ENDED ON MAY 13, 2024, AND
MAY 30, 2024, RESPECTIVELY
    * MORPHOSYS AG - NOVARTIS WILL OFFER MORPHOSYS SHAREHOLDERS
EUR
68.00 PER SHARE IN CASH, CORRESPONDING TO ITS PRECEDING TAKEOVER
OFFER
    * MORPHOSYS AG - DELISTING OFFER DOCUMENT IS EXPECTED TO BE
PUBLISHED BY NOVARTIS IN EARLY JULY 2024
    * MORPHOSYS AG - BOTH DELISTING FROM FRANKFURT STOCK
EXCHANGE AND
DELISTING FROM NASDAQ ARE EXPECTED TO TAKE PLACE IN Q3 OF 2024
    * MORPHOSYS AG - DELISTING OFFER DOCUMENT IS EXPECTED TO BE
PUBLISHED BY NOVARTIS IN EARLY JULY 2024 AFTER GERMAN FEDERAL
FINANCIAL SUPERVISORY AUTHORITY ("BAFIN") HAS APPROVED ITS
PUBLICATION

Source text for Eikon:  ID:nEQ9wGspya 
Further company coverage:  MORG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))